Century Therapeutics (IPSC) Shares Outstanding (2020 - 2026)

Century Therapeutics (IPSC) has reported Shares Outstanding (Entity) for 7 consecutive years, with $180.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 109.07% year-over-year to $180.1 million; the TTM figure through Mar 2026 stood at $180.1 million (up 109.07% YoY), while the FY2025 annual figure was $87.5 million, up 1.96% from the prior year.
• Shares Outstanding (Entity) grew to $180.1 million in Q1 2026 per IPSC's latest filing, from $87.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $180.1 million in Q1 2026 and bottomed at $57.6 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $77.5 million across 5 years, with a median of $64.8 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 631.48% — and 2025, when it advanced 1.96%.
• Century Therapeutics' Shares Outstanding (Entity) stood at $58.5 million in 2022, then increased by 3.18% to $60.3 million in 2023, then surged by 42.26% to $85.8 million in 2024, then advanced by 1.96% to $87.5 million in 2025, then soared by 105.79% to $180.1 million in 2026.
• Business Quant data shows IPSC's Shares Outstanding (Entity) at $180.1 million in Q1 2026, $87.5 million in Q4 2025, and $86.5 million in Q3 2025.